- A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
-
Cho BC, Kim NK, Lim BJ, Kang SO, Sohn JH, Roh JK, Choi ST, Kim SA, Park SE
- KMID: 1716527
- Yonsei Med J.
- 2005 Aug;46(4):555-561.
- doi: 10.3349/ymj.2005.46.4.555
Tailgut cysts (TGCs) are rare congenital cysts that occur in the retrorectal or presacral spaces. Although most tailgut cysts have been reported as benign, there have been at least 9... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
-
Kim J, Lee YS, Hwang IK, Kang BK, Cho JY, Yoon YS, Han HS, Hwang JH
- KMID: 2133302
- J Korean Med Sci.
- 2015 Mar;30(3):259-263.
- doi: 10.3346/jkms.2015.30.3.259
The role of carcinoembryonic antigen (CEA) in pancreatic cancer remains poorly understood. Therefore, this study aimed to determine whether CEA is complementary to carbohydrate antigen 19-9 (CA19-9) in prognosis prediction... -
- CITED
-
- Close
- SHARE
-
- Close
- Carcinoembryonic Antigen Level Can be Overestimated in Metabolic Syndrome
-
Kim KN, Joo NS, Je SY, Kim KM, Kim BT, Park SB, Cho DY, Park RW, Lee DJ
- KMID: 1785961
- J Korean Med Sci.
- 2011 Jun;26(6):759-764.
- doi: 10.3346/jkms.2011.26.6.759
Carcinoembryonic antigen (CEA) levels can be affected by many factors and metabolic syndrome is also a candidate. This study examined the relationship between CEA levels and metabolic syndrome using the... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Carcinoembryonic Antigen for Monitoring Tumor Progression during Palliative Chemotherapy in Metastatic Colorectal Cancer
-
Kim G, Jung EJ, Ryu CG, Hwang DY
- KMID: 1776926
- Yonsei Med J.
- 2013 Jan;54(1):116-122.
- doi: 10.3349/ymj.2013.54.1.116
PURPOSE: To evaluate the efficacy of carcinoembryonic antigen (CEA) measurement for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer. MATERIALS AND METHODS: Forty-eight patients with initially unresectable metastatic colorectal... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
-
Lee KJ, Yi SW, Chung MJ, Park SW, Song SY, Chung JB, Park JY
- KMID: 1727877
- Yonsei Med J.
- 2013 May;54(3):643-649.
- doi: 10.3349/ymj.2013.54.3.643
PURPOSE: To investigate the use of pretreatment carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) as prognostic factors to determine survival in pancreatic adenocarcinoma. MATERIALS AND METHODS: A retrospective review of... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
-
Kim NH, Lee MY, Park JH, Park DI, Sohn CI, Choi K, Jung YS
- KMID: 2418926
- Yonsei Med J.
- 2017 Sep;58(5):918-924.
- doi: 10.3349/ymj.2017.58.5.918
PURPOSE: Limited data are available regarding the association between circulating serum carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA 19-9) concentrations and colorectal adenoma. We aimed to investigate whether elevated... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer
-
Park IJ, Kim HC, Yu CS, Yoo JH, Kim JC
- KMID: 1712744
- J Korean Med Sci.
- 2005 Aug;20(4):624-627.
- doi: 10.3346/jkms.2005.20.4.624
Serum carcinoembryonic antigen (s-CEA) is used to detect recurrence and predict prognosis in colorectal cancer. However, the cutoff values of s-CEA for prognosis have not been determined. We therefore tried... -
- CITED
-
- Close
- SHARE
-
- Close
